- Home
- XNET vs OLMA Comparison
XNET vs OLMA Comparison
Compare XNET & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNET
- OLMA
- Stock Information
- Founded
- XNET 2003
- OLMA 2006
- Country
- XNET China
- OLMA United States
- Employees
- XNET 1216
- OLMA N/A
- Industry
- XNET Computer Software: Prepackaged Software
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- XNET Technology
- OLMA Health Care
- Exchange
- XNET Nasdaq
- OLMA Nasdaq
- Market Cap
- XNET 373.0M
- OLMA 289.0M
- IPO Year
- XNET 2014
- OLMA 2020
- Fundamental
- Price
- XNET $5.53
- OLMA $4.38
- Analyst Decision
- XNET
- OLMA Strong Buy
- Analyst Count
- XNET 0
- OLMA 4
- Target Price
- XNET N/A
- OLMA $24.50
- AVG Volume (30 Days)
- XNET 652.6K
- OLMA 687.3K
- Earning Date
- XNET 05-15-2025
- OLMA 05-13-2025
- Dividend Yield
- XNET N/A
- OLMA N/A
- EPS Growth
- XNET N/A
- OLMA N/A
- EPS
- XNET N/A
- OLMA N/A
- Revenue
- XNET $331,614,000.00
- OLMA N/A
- Revenue This Year
- XNET N/A
- OLMA N/A
- Revenue Next Year
- XNET N/A
- OLMA N/A
- P/E Ratio
- XNET N/A
- OLMA N/A
- Revenue Growth
- XNET N/A
- OLMA N/A
- 52 Week Low
- XNET $1.46
- OLMA $2.86
- 52 Week High
- XNET $7.19
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- XNET 56.11
- OLMA 41.54
- Support Level
- XNET $5.29
- OLMA $4.80
- Resistance Level
- XNET $7.19
- OLMA $5.61
- Average True Range (ATR)
- XNET 0.50
- OLMA 0.43
- MACD
- XNET 0.04
- OLMA -0.03
- Stochastic Oscillator
- XNET 40.52
- OLMA 20.32
About XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.